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1. Introduction 
Salmonella are ubiquitous, host-adapted or zoonotic human and animal pathogens and, after 
Campylobacter, the genus is the second most predominant bacterial cause of foodborne 
gastroenteritis Worldwide (Giannella, 1996; Smith, 2003). Numerous foods (meat, seafood, 
eggs, fresh horticulture, table eggs and poultry) have been associated with Salmonella 
carriage or contamination (FAO/WHO, 2002; Jay et al., 2003; Foley and Lynn, 2008).  
Poultry meat has been associated frequently and consistently with the transmission to 
humans of enteric pathogens, including Salmonella and Campylobacter (Food and Agriculture 
Organisation of the United Nations and the World Health Organisation [FAO/WHO], 2002; 
Codex Alimentarius Commission, 2004; EFSA, 2007; Lutful Kabir, 2010; Vanderplas et al., 
2010 and Cox and Pavic, 2010). Moreover, Callaway et al. (2008) stated that the “link between 
human salmonellosis and host animals is most clear in poultry” and that raw eggs and 
undercooked poultry are considered by the entire community to be hazardous. Eggs have 
been implicated as vehicles in numerous outbreaks of salmonellosis; in particular, eggs have 
been a major vehicle of transmission of strains of Salmonella serovar Enteritidis, though the 
incidence of disease associated with this particular mode of transmission has decreased 
dramatically (Braden, 2006).  
There have been large increases, in Australia and the United States of America (6.5 times), in 
per capita consumption of poultry products since 1910, compared with modest increases 
(20%) in consumption of beef and pork (Buzby and Farah 2006; ABARE, 2008). Chicken 
meat is close to replacing beef as Australia’s preferred meat, largely because of the 
industry’s success in reducing real (net of inflation) supply costs and hence price to 
consumers, and through continuous product innovation. The chicken meat industry has 
reduced supply costs by consistently raising both on-farm and off-farm productivity over 
several decades through a combination of better management, genetic improvement, 
economies of scale and mechanisation in processing (ABARE, 2008). 
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With projected increases in poultry consumption and the association of Salmonella with 
poultry products, the industry needs to employ specific and economic strategies to minimise 
risk to public health. The production of commercial poultry uses a pyramidal multiplier 
structure, with breeders at the apex and broilers at the base.  
The two broad approaches to Salmonella control are ‘top down’ and ‘bottom up’, with the 
latter used widely in Australia. This approach uses spin chiller chlorination within the 
processing plant for reduction of microbial populations. This method has limited success in 
reduction of Salmonella prevalence and, with consumer choices moving towards ‘natural’ 
(chemical free) products, has lead to experimentation with and application of ‘top down’ 
intervention strategies. A ‘top down’ approach, using vaccination at breeder level, can be 
very cost-effective and is a proven method of flock protection for both viral and bacterial 
pathogens such as Infectious Bursal Disease Virus, Inclusion Body Hepatitis and Mycoplasma 
(Marangon and Busani, 2007). 
The increasing costs or impracticality of improvements in biosecurity, hygiene and 
management, coupled with the increasing problems associated with antibiotic resistance, 
suggests that vaccination in poultry will become more attractive as an adjunct to existing 
control measures (Zhang-Barber et al., 1999). 
Although Salmonella is typically not a pathogen in the gut of the chicken, systemic infection 
can cause serious disease (fowl paratyphoid) in the bird (Lutful Kabir, 2010). This usually 
results from contamination of egg shells from infected breeder hens and spread of the 
organism into the respiratory tract during hatching which may result in potentially high 
morbidity and mortality in young chicks (Lutful Kabir, 2010). 
Salmonella vaccines available to the poultry industry are based on inactivated or killed cells 
or genetically attenuated strains (Methner et al., 1999; Babu et al., 2003). However, with 
concerns in Australia over the use of genetically modified organisms in the food chain, until 
2008, only inactivated vaccines were available for use (Anonymous, 1999).  
Vaccination against Salmonella was first demonstrated to be successful in decreasing poultry 
mortality due to the poultry-specific Salmonella serovar Gallinarum (Smith, 1956). This 
success, and the Enteritidis disaster in table eggs during the late 1980s that occurred in 
Europe and the United Kingdom, lead to the development of a Salmonella Enteritidis 
vaccine, which reduced the prevalence of the serovar in poultry. This was followed by a 
combined (dual) vaccine containing serovars Enteritidis and Typhimurium that again aided 
in the reduction of carriage in flocks (Clifton-Hadley et al., 2002; Woodward et al., 2002).  
Van Den Bosch (2003) reported success with inactivated Salenvac® vaccines in the European 
poultry industry, which has been associated with a decline in the presence of S. Enteritidis 
and Typhimurium in England. Salenvac®T is a bivalent S. Typhimurium and S. Enteritidis 
bacterin-based vaccine, developed from the monovalent Salenvac® S. Enteritidis bacterin 
(Clifton-Hadley et al., 2002).  
Based on these studies, production of a trivalent vaccine was initiated in 2004 in association 
with Intervet Schering-Plough Australia Pty Limited, incorporating the three most 
predominant Salmonella serovars, Typhimurium (group B), Mbandaka (group C) and Orion 
(group E), from a commercial poultry meat producer, determined through in-house analysis 
of environmental samples from breeder houses.  
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Australian poultry companies need to ensure that their operations are free of the specific 
serogroup D serovars that are present in poultry, including the host-specific chicken 
pathogens, Gallinarum and Pullorum (Barrow et al., 1994) as well as Enteritidis (Arzey, 
2005), a serovar of significant public health concern. This is achieved by ongoing monitoring 
of hatcheries, feed mills and poultry rearing houses, and culling all positive flocks; therefore 
these serovars are no longer endemic, with only sporadic cases in Australian broiler and 
layer flocks (Davos, 2007).  
On the other hand, Salmonella Typhimurium, which is associated typically with at least 35% 
of human cases of salmonellosis in Australia, is present in 14% of broiler and 17% of layers 
isolates (Davos, 2007). Furthermore, other predominant Salmonella serovars isolated from 
broilers and layers include Sofia (38 % broiler, 0% layer), Infantis (10% broiler, 8.9% layer), 
Montevideo (8.8% broiler, 5.7% layer), Muenster (7.8% broiler, 0% layer) and Mbandaka 
(<1.7% broilers, 10.5% layers), (Davos, 2007).  
The vaccinated or naturally challenged hen protects her progeny through maternal 
antibodies (IgY) transported into the egg yolk (Kowalczyk et al., 1985). These maternal 
antibodies offer some protection to the hatchling until its own immune system is fully 
functioning (Kowalczyk et al., 1985). The IgY suspended in egg yolk can be easily extracted 
via chemical methods, and purified (Ko and Ahn, 2007). Therefore Salmonella vaccinated 
hens can transfer to the yolk IgY that can be extracted, measured and used prophylactically 
(in feed) to protect young chicks from initial Salmonella colonisation (Vanderplas et al., 2010; 
Cox and Pavic, 2010).  
The objectives of this research were to develop an autogenous tri-vaccine to prevalent 
poultry serovars, test whether heterologus protection is possible, and if specific anti-
Salmonella IgY, extracted from the eggs from vaccinated hens, confers prophylactic 
protection to day old chicks. 
2. Material and methods 
The methods summarised in this section are divided into three sections, with general, 
vaccine trial and prophylactic methods individually described. 
2.1 General methods 
The methods summarised in this section describe the common techniques that were used 
throughout the experimental work. These methods include: the Salmonella strains, challenge 
suspension and isolation testing; blood and yolk collection and their subsequent  testing 
with the anti-Typhimurium ELISA; trial farm setup and the animal ethics requirements. 
2.1.1 Salmonella strains 
All Salmonella enterica subsp. enterica strains used in this research (Table 1) were from Birling 
Avian Laboratories Reference Collection, isolated from the field (production environment), 
and typed by the Institute of Medical and Veterinary Science (IMVS) in accordance with the 
White-Kauffmann-Le Minor scheme (Grimont and Weill, 2007). 
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Serogroup Antigenic structure Serovar Abbreviation 
B 1,4,[5],12 f,g,s [1,2] [z27],[z45] Agona SA1 
B 1, 4 ,[5],12 i 1,2 Typhimurium ST12 
C 6,7,14, r 1, 5 [R1..], [z37], [z45], [z49] Infantis SI1 
C 6,7,14 z10 e,n,z15 [z37],[z45] Mbandaka SM1 
E 3, {10}, {15, 34}, y 1, 5 Orion SO1 
E 3,{10}{15} k 1,5 Zanzibar SZ1 
Table 1. Salmonella challenge strains belonging to serogroups B, C and E with their 
respective abbreviation used in the text. 
Pure cultures on nutrient agar (NA, Oxoid Thermo Fisher, CM3) were harvested with a 
cotton swab (Copan, Ref 8155CIS, Italy.) and preserved (10 per serovar) in Cryovials (PRO-
LAB Diagnostic, REFPL.170/M, Ontario, Canada) stored at -70ºC. 
2.1.2 Salmonella suspension for challenge 
For each Salmonella strain, a bead from a Cryovial (PRO-LAB Diagnostic, REFPL.170/M, 
Ontario, Canada) was incubated in 100 mL of buffered peptone water (BPW, Oxoid Thermo 
Fisher, CM509, Hampshire, UK) to produce a seed culture. Purity of the culture was checked 
on NA and identity confirmed serologically using antisera (PRO-LAB Diagnostic Ontario, 
Canada; Refs TL6002 [O], TKL6001 [H], RL6011-04 [B], PL6013 [C] and PL6017 [E]).  
After purity was confirmed and serology determined, isolated colonies were selected and 
suspended in BPW (4 mL) to give a 75% transmittance (1.0 McFarland) equating to 2 x 108 
cfu / mL (bioMérieux, 47100-00 DR 100 Colorimeter, Marcy l’Etoile, France). The target 
dosage required was achieved through decimal dilution, with the target dilution used as 
inocula in challenge or recovery experiments, in accordance with AS/NZS5013.11.1 (2004) 
and confirmed by spread plate enumeration on SM®ID2 (bioMérieux, Ref 43621, Marcy 
l’Etoile, France). 
2.1.3 Salmonella isolation, confirmation and serological testing 
All testing was performed at a laboratory accredited by the National Association of Testing 
Authorities (Australia) in accordance with ISO 6579:2002. The Salmonella serovars, listed in 
Section 2.1.1, were isolated from commercial poultry houses (from visceral emulsions, drag 
swabs and faeces) on the Eastern seaboard of Australia.  
Samples were initially emulsified 1:10 in BPW and incubated at 37 ºC for 24 h (standard 
incubation temperature unless otherwise stated). Aliquots of 1000 µL and 100 µL were 
transferred into selective Muller Kauffman (MK, bioMérieux, Ref 42114, Marcy l’Etoile, 
France) and Rappaport-Vassiliadis (RV, bioMérieux, Ref 42110) (incubated at 42 °C for 24 h) 
broths respectively.  
The following validated modifications to ISO 6579:2002 were used. The selective-differential 
plating agars were Hektoen and XLD (Oxoid Thermo Fisher, PP2027, Adelaide, Australia) 
and suspect positives (black colonies with clear edges) were confirmed on chromogenic 
SM®ID2 instead of the standard biochemical tests (urease, sorbitol fermentation and iron 
agar reactions).  
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Presumptive Salmonella were serologically confirmed with poly-O and poly-H antisera (Pro-
Labs Diagnostic, Refs TL6002 and TKL6001, Ontario, Canada) after subculture onto two 
slopes of NA and employing the slide agglutination technique. The confirmed Salmonella 
isolates (each on a NA slope) were forwarded to the Australian Salmonella Reference 
Laboratory at the Insitute of Medical and Veterinary Science (IMVS) for complete serological 
and phage typing. 
2.1.4 Blood collection 
Blood was collected using a 21-gauge needle (Greiner bio-one, 450072, Germany.) into a 2 
mL serum collection tube (Vacuette, 454096, Greiner bio-one, Austria) and, after clotting, 
transported to the laboratory in chilled containers. The serum was decanted into 1200 ǍL 
plasma tubes (Scientific Specialist, 1750-00, CA., USA) and the presence of antibodies to the 
vaccine was determined using a commercially available Salmonella Typhimurium ELISA kit 
(Guildhay, {trading as x-OVO since 2008, Castle Court, UK}, Flockscreen™, Cat. No V020-
43308), according to the manufacturer’s instructions (2.1.7). 
Initially, the serum was diluted (1:500) by adding 5 ǍL of serum into 2.5 mL reconstituted 
sample diluent (2.1.7) in plastic 5 mL tubes (Techno-Plas, 10255001, SA, Aust) and inverted a 
total of three times to mix. 
2.1.5 Egg yolk collection 
Eggs were collected after laying by mature hens and transported whole to the lab where 
they were broken and the yolk separated from the white using a domestic egg separator. 
The yolk was then poured into a 70 mL sterile jar (Techno-Plas, 10431011, SA, Aust) from 
which a 200 ǍL aliquot was removed and added to 1.8 mL of reconstituted wash buffer and 
mixed by repeated (5 x) aspiration. The yolk was further diluted (1:50) by pipetting 50 ǍL 
into 2.5 mL of reconstituted sample diluent buffer (2.1.7). 
2.1.6 Immunoglobulin Y extraction 
Only Typhimurium ELISA-positive or suspect (2.1.7) egg yolks from Section 2.1.5 were used 
for IgY extraction. The method selected was the water dilution method described by Staak et 
al. (2001). Initially, the weighed ELISA positive egg yolks were diluted 1:5 w/v with 
distilled water, mixed vigorously by vortexing (15 s) and frozen at -20 ºC for 72 h. Post-
freezing the yolk suspension was thawed slowly in a refrigerator at 4 ºC.  
The thawed yolk water suspension was transferred into centrifuge tubes (50 mL) (Greiner®, 
T2318, Sigma-Aldrich, St Louis, MO, USA) and centrifuged (Eppendorf, 5810R, Hamburg, 
Germany) at 2,800 x g (Equation 1) for 20 minutes at room temperature. 
RCF = 1.118 x 10-5rN2 
g = r(2πN)2 / RCF 
RCF = Relative centrifugal force. 
r = rotation radius in centimetres. 
N  = revolution per minute 
g = gravitational force 
π = Pi 
Equation 1. Calculation of centrifugal g forces. 
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Post-centrifugation, the supernatant was decanted into a volumetric cylinder and the 
precipitate discarded. To each millilitre of supernatant, 0.27 g of ammonium sulphate (‘salt’) 
was added, mixed by vortexing (15 s) and incubated at room temperature for 2 h. Post-
incubation the ‘salt’-yolk suspension was centrifuged as mentioned previously and the 
supernatant was discarded. 
The precipitate containing IgY was resuspended, in 24 mL of ammonium sulphate (2 M), 
vortexed (15 s) and incubated at room temperature for 40 min. After incubation, the salt-
yolk suspension was re-centrifuged and the supernatant discarded. The final precipitate of 
crude IgY was resuspended (vortex 15 s) in 5 mL of phosphate buffered saline, transferred 
to a 10 mL sealable test tube (Techno-Plas, 10281003, SA, Aust.) and stored at 4 ºC. 
2.1.7 Typhimurium ELISA method 
The ELISA was performed in accordance with the manufacturer’s  instructions (Guildhay, 
Castle Court, UK). Briefly, kits were allowed to reach room temperature and the wash buffer 
(100 mL {phosphate buffer with ProClin 0.63 % v/v} to 1900 mL deionised water) and 
sample diluent (100 mL {phosphate buffer with protein stabiliser and ProClin 0.63% v/v} to 
900 mL deionised water) prepared.  
Into individually pre-coated (Typhimurium somatic liposaccaride antigen) ELISA strips 
containing eight wells, 50 ǍL was dispensed of positive controls (x2), followed by negative 
controls (x2) and finally the test sample(s). The ELISA plate(s) were covered with an 
adhesive plastic film (Sealplate, 100-seal-PLT, Excel Scientific Inc, Victorville, CA, USA), 
mixed by gently tapping the side and then incubated at 37 ºC for 30min.  
Post-incubation, after removal of the adhesive cover, each well was washed four times (100 
ǍL per well/per wash cycle) in a pre-programmed ELISA Plate washer (Immunowash, 1575, 
BioRad, CA, USA) with the reconstituted wash buffer. After washing, the plates were dried 
(five firm taps) by inverting them over paper towel. Once dry, 50 ǍL of antibody-enzyme 
conjugate (donkey anti-chicken IgG {Guildhay, Castle Court, UK}) was pipetted into each 
well. The plate was resealed, mixed and incubated as described previously. 
Following incubation, the wells were washed as above, then 50 ǍL of ELISA substrate 
reagent (alkaline phenolphthalein monophosphate and enzyme co-factors in a 
diethanolamine buffer) were added, and the plates covered, mixed and incubated at 37 ºC 
for 15min. The final step was to add 50 ǍL of ELISA stop solution (1 M sodium hydroxide), 
ensuring that any bubbles formed were removed, then the plates were analysed in a blanked 
Microtitre Plate Reader (Vmax Kinetic microplate reader, Molecular Devices, CA, USA) at 
ǌ550 nm. 
The Guildhay ELISA can detect anti-Typhimurium antibodies, within serum or egg yolk, at 
an initial dilution of 1:500. After the optical density (OD) all wells was measured at ǌ550 nm, 
the sample OD was compared to the mean positive controls OD (Equation 2) to produce the 
Sample / Positive (S/P) ratio. Using Equation 3 the S/P ratio was converted into a titre. 
Sample Optical Density – mean Negative Optical Density 
Mean of Positive Optical Density – mean Negative Optical Density 
Equation 2. Sample to Positive ratio calculation. 
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log10 titre = 1.046 x ( log10 S/P) + 3.524 
Titre = antilog of log10 titre 
Equation 3. Salmonella Typhimurium titre calculation from S/P ratio. 
The Typhimurium titres were initially calculated manually, though software (Guildhay, 
Castle Court, UK) is available that performs all the calculations and reports the values as 
OD, SP or titres. According to the kit manufacturer (Guildhay) the lowest threshold for a 
positive was an SP ratio > 0.25 (titre > 785, OD > 0.173), negative SP < 0.15 (titre < 459, OD < 
0.15) and a suspect band SP 0.15 to 0.25 (titre 460 to 784, OD 0.15 to 0.173).  
2.1.8 Trial farm set up 
The trial house used was an insulated broiler house with side curtains for ventilation 
control, equipped with two gas-fired space heaters for brooding, and internal fans and roof 
sprinklers for cooling. The house was divided into 32 individually numbered floor pens, 2.5 
x 3 m, with individual bell drinkers and two tube feeders. 
To minimise cross-contamination and identify the presence of non-inoculant Salmonella the 
following procedure was used in all trials. Prior to the trial all pens were disinfected using a 
synthetic phenol (Farm Fluid™, Antec International, Suffolk, UK), drag-swabbed and tested 
for the presence of Salmonella. Fresh litter (wood shavings) was spread evenly across each 
pen and drag-swabbed again. A footbath, containing a commercially available iodophor-
based sanitizer (Sanichick, Ranvet, Sydney, Australia), was placed outside each of the 
pens. An empty pen was left between all populated pens, with controls located furthest 
from the entrance; all routine maintenance started from the controls and worked backwards. 
Vermin baits, pest strips and an Insectocuter were placed around the house.  
The pens were divided into treatment sets, i.e. vaccination, (north side of house) and control, 
i.e. non-vaccinated (south side of house), with feed and water supplied ad libitum. 
Disposable overalls (Fabri-cell, 05250XL, Vic. Aust.), dust masks (3M, 9320, UK) and gloves 
(Livingstone Int, GLVLPF100LG-T, NSW, Aust.) were worn inside the house at all times and 
changed between treatment and control groups. Biohazard bags (Bacto, BCWB66112, 
Sydney, Aust.) were used to remove contaminated waste, litter and to transport culled or 
naturally deceased chickens. Hands were washed with an iodophor-based disinfectant, prior 
to leaving the house. Post-trial the house was disinfected with phenolic-based chemicals and 
drag-swabbed. 
At the termination date, the chickens were euthanized by lethal intraperitoneal injection 
with 0.5 mL/kg pentobarbitone (Lethabarb®, Virbac Pty Ltd, 1PO643-1, Carros Cedex, 
France). The carcasses were transported in biohazard bags back to the laboratory and the 
caeca were removed aseptically by a veterinarian, cut into ten pieces and placed into a single 
sterile 250 mL sample jar (Techno-Plas, 10453003, SA, Aust.), diluted as per specific 
procedure with BPW, then incubated for detection as described in Section 2.1.3. 
2.1.9 Animal ethics 
The Birling Animal Ethics Committee (BAEC), supervised all experimental work in 
accordance with the Animal Research Act of NSW (1985) and Regulations (2005), following 
the NHMRC (National Health and Medical Research Council) guidelines (2008) and 
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NHMRC/ARC (National Health and Medical Research Council, Australian Research 
Council and Universities Australia) Code of Conduct (2007). When the project was 
approved, it was designated with a unique BAEC number and a time period for completion. 
2.2 Vaccine trial 
This section describes the process from the original controlled animal pen to field trials, 
which occurred over a period of three years. 
2.2.1 Vaccine manufacture and administration 
Intervet Schering-Plough Australia was commissioned to produce an autologous trivalent 
inactivated vaccine using proprietary Salenvac® technology from poultry field isolates of 
Typhimurium, Mbandaka and Orion. Strains were grown on iron-depleted agar, improving 
specifically the expression of the antigenic iron regulatory proteins (IRPs), further 
stimulating the humoral response and increasing antibody titres (Van Den Bosch, 2003). The 
trivalent vaccine was produced using equal amounts of cell suspension (3x108 cfu / mL), 
combined with an aluminium hydroxide adjuvant, and administered to hens 
intramuscularly into the breast, at 12 and 17 weeks of age. 
2.2.2 Experimental animals 
In Experiment 1 a total of 50 vaccinated and 50 non-vaccinated, 20-week-old Cobb breeders 
were placed into trial pens at a minimum of 12 per group, with the remainder used as 
negative controls. These were obtained from a commercial broiler breeder farm where the 
vaccine regimes were administered under commercial conditions. All birds where 
individually labelled with leg or wing tags and blood and rectal swabs collected and tested 
five days prior to challenge.  
In Experiment 2 a total of 100 non-vaccinated, 12 week old Cobb breeders were placed into 
the trial pens (12 per group) as mentioned previously. In Experiment 3 Cobb broiler day old 
chicks (n = 100) were sourced from a commercial hatchery from vaccinated (n = 50) and non-
vaccinated parents (n = 50). 
2.2.3 Adult hen challenge design and trial (experiment 1 and 2) 
The number of birds required for each experiment was calculated using statistical tables as 
described by Martin et al., (1988) to determine the lowest number of repeats required to 
demonstrate a difference of 20% prevalence between vaccinated (expected 30% prevalence) 
and non-vaccinated (expected 50% prevalence) groups, at 90% confidence.  
As this study involved a new vaccine, the standard deviation of titres following vaccination 
was unknown. Therefore, 12 birds per group allowed estimation of the average result within 
a bound of 0.5 x standard deviation from a flock of >300 birds, at 90% confidence (Hancock 
et al., 1988).  
Each trial required the use of only half the trial house (2.1.8) and therefore the other half was 
sectioned off. The controls were placed furthermost away from the entrance to minimise any 
cross-contamination. The challenge groups were placed in pens that were opposite each 
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other. Each bird was challenged with 250 µl of the 107 cfu Salmonella suspension via oral 
gavage using a 2 mL variable volume pipette (Finnpipette stepper, 4540000, Thermo 
Electron Corp. Waltham, MA, USA). 
The initial experiment (Experiment 1) involved autologous challenge (i.e. with the parent 
vaccine strains) and the subsequent experiment (Experiment 2) involved heterologous 
challenge, using alternative, poultry-associated serovars from the same respective 
serogroups as the vaccine strains: Agona (SA1, serogroup B); Infantis (SI1, serogroup C), 
and; Zanzibar (SZ1, serogroup E). An additional group, challenged with Typhimurium, was 
used to show repeatability. Cloacal swabs were taken at days 0, 3 and 14 post-challenge. At 
day 21 post-challenge each bird was bled, humanely euthanized and their caeca removed for 
culture.  
Prior to the heterologous (Experiment 2) trial, the hens were sourced as 10-week old birds, 
prior to vaccination (12 weeks of age), from a commercial broiler breeder farm that was 
Salmonella-free (confirmed by testing of drag swabs and faeces). These hens were 
individually tagged and bled, then hand-vaccinated via intra-muscular injection and bled 
again at 14, 16, 18 and 20 weeks of age.  
2.2.4 Progeny challenge trial (experiment 3) 
In this trial, 100 chicks were obtained from a commercial hatchery, from eggs produced by 
vaccinated (n = 50) and non-vaccinated birds (n = 50). The chicks were vaccinated according 
to current broiler practices (Marek’s Disease, Infectious Bronchitis and Newcastle Disease). 
Chicks were identified as to their dams’ vaccination status by toe web marking and were 
placed in the trial house at 10 chicks per pen. Pen dividers were used to keep birds close to 
feed and water, with 2 pens of chicks for each progeny group and challenge (total of 10 
pens).  
At arrival, blood samples were collected from 12 euthanized (cervical dislocation) chicks of 
vaccinated and non-vaccinated groups, for S. Typhimurium antibody assay (2.1.7). The 
paper from each box of chicks delivered to the farm was cultured for Salmonella as described 
in Section 2.1.3. The remaining chicks were challenged with S. Typhimurium ST12, 104 or 108 
cfu per bird by oral gavage, with controls receiving the diluent buffered peptone water 
On days 0, 3 and 14, cloacal swabs were collected, from a random sample of five birds per 
pen, for individual Salmonella culture, with blood samples collected via wing bleeding, on 
days 7, 10 and 14. On day 21 all birds were bled prior to being euthanized by lethal injection 
(Lethabarb) and their caeca removed for Salmonella testing. All birds were weighed on days 
7, 14 and 21. 
Any bird that appeared sick, as described in the bird health monitoring sheet, was 
euthanized immediately, weighed, necropsied and the caeca cultured for Salmonella (2.1.3). 
2.2.5 Serology 
Blood was collected, using a 20-gauge needle, into a serum collection tube and, after 
clotting, transported to the laboratory in containers chilled with ice bricks. The presence of 
antibodies to the vaccine was determined using a commercially available Salmonella 
Typhimurium ELISA kit, according to the manufacturer’s instructions (2.1.7).  
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An additional commercial antigen-based ELISA (Idexx, Art.Nr. 99-44100, Liebefeld-Bern, 
Switzerland), for determination of titres against Salmonella serovars prevalent in swine 
(Typhimurium, Infantis and Enteritidis), was sourced and used according to manufacturer’s 
instructions, with the following modification. All serum dilutions were 1:500, the previously 
mentioned x-OVO Guildhay conjugate, substrate and stop solution were used, and the 
ELISA plates read at 550nM.  
2.2.6 Longitudinal analysis 
The prevalence of serovars over time was determined by performing drag swabs on all 
broiler breeder flocks from two Australian poultry companies, in three states (New South 
Wales, Victoria and South Australia), which implemented the Salmonella tri-vaccine protocol 
described in 2.2.2. Swabs were taken at 6, 14, 18, 22, 33, 43 and 53 weeks of age. The 
Salmonella prevalence data were calculated for the years 2003 (pre vaccination), 2004 (during 
vaccination) and 2005 (post vaccination). 
These data (2003 to 2005) were analysed initially for annual prevalence (total positives / 
total samples received) and the monthly prevalence was calculated by dividing the monthly 
positive by total tested. This same data set was used to calculate the age based prevalence 
and determine the serovars present. 
The flocks mentioned previously were also bled (2.1.4) regularly (22, 32, 42 and 52 weeks of 
age) and the serum (n = 12) was tested for anti-Typhimurium antibodies using ELISA (2.1.7). 
From these data the flock immunity, the number of positive sera from the total tested (n = 
12), and the flock mean was calculated. The flock serum data were sorted by flock age 
(weeks) and descriptive statistics (mean, medium, standard deviation and 95% confidence 
limits) were calculated.  
The final analysis was to compare the effects of vaccination upon Typhimurium colonised 
chicks (<12 weeks of age). This analysis was performed by reviewing flock data 
(Typhimurium antibodies titre and corresponding drag swabs) that contain Typhimurium 
colonised birds, based on the whole of life cycle throughout 2004/2005. These colonised 
flocks were sorted upon age (weeks) with the corresponding serology and drag swab data 
added. A flock was deemed negative for Typhimurium if it had two consecutive negative 
results (i.e. 18 woa positive, 22 woa negative, 33 woa negative then the flock was deemed 
negative at 22 woa) and that initial age was plotted against the flock mean Typhimurium 
titre. These data were also used to evaluate if there was a statistical (χ2) relationship between 
high (>1000) and low (<1000) mean antibody titre and flock Typhimurium status at point of 
lay (25 woa). 
2.2.7 Statistical analysis 
Qualitative data were converted to numerical data, by assigning (0) for non-detection and 
(1) for detection, and analysed in a 2 x 2 contingency table, as described by Petrie and 
Watson (1999). Statistical significance (P ≤  0.05) was determined using either the Fisher 
exact test (any cell with ≤5 observations) or the Chi squared test (all cells had >5 
observations).  
The Mantel-Haenszel stratified contingency table test was employed to compare similar 
treatments stratified across experiments (Thrusfield, 2005). The Student t-test was used to 
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evaluate the null hypothesis on vaccination status based on anti-Salmonella antibody levels 
among paired groups of hens. A difference was considered significant at P  0.05. All 
analyses were performed using Statistica™ (StatSoft Inc, 2001, Tulsa, OK, USA). 
2.3 Immunoprohylaxis trial 
2.3.1 Dried egg yolk preparation 
Non-fertile eggs were sourced from a commercial poultry company that routinely 
administers the trivaccine (2.2.1) to their flocks. The eggs (n = 400) from three different farms 
were sourced from young hens with high (> 1000) anti-Typhimurium serum antibody titres. 
Upon arrival at the laboratory, 20 eggs were tested for the presence of yolk antibodies to 
Salmonella using the Salmonella Typhimurium ELISA kit (2.1.5 and 2.1.7). The remaining egg 
yolks were pooled into approximately 100 g lots and homogenised by vortexing for 15 
seconds. These pooled eggs were then frozen and freeze dried (Avanti JE, Beckman Coulter, 
Bree, CA. USA). 
The dried egg yolk lots were resuspended (weight/volume) in PBS buffer (2.1.5) and tested 
for the presence of anti-Salmonella Typhimurium antibodies using ELISA (2.1.7). The lots 
were composited into one container and homogenised by vigorous shaking and tested (n = 
20) for anti-Salmonella antibody, as previously described (2.1.7). The dried egg yolk powder 
was then stored in an air-tight container until required.  
2.3.2 Crude extraction of IgY 
The freeze-thaw technique (Staak et al., 2001) with ammonium salt precipitation, described 
fully in Section 2.1.6, was used. 
2.3.3 Provision in feed 
The feed was divided into three lots:  the first lot incorporated 3% w/w IgY egg yolk (dT-
IgY) as described by Gurtler et al. (2004). Dried egg yolk powder was mixed through a 
standard commercial broiler breeder starter ration supplied by a local mill. The second lot 
included dT-IgY re-composited in water (w : v) and, in the final lot, the dT-IgY was re-
composited (w : v) in crude IgY extract. 
The dosage of dT-IgY was calculated at 3% of total daily feed intake (1.42 g/chick) from the 
trial mid-point age (11 days of age) according to breeder specifications (Anonymous, 2007). 
All the feeds were prepared in 250 mL containers and fed to the chicks. The re-composited 
dT-IgY was initially smeared onto the beaks of individual chicks and the remainder spread 
in a straight line on chick paper, prior to supplying the standard ration.  
The residual from each of the lots (in 250 mL containers) was weighed and an initial dilution 
(1 : 10) was made with Salmonella Typhimurium ELISA buffer. This suspension was diluted 
(1:2) in plasma tubes and Typhimurium IgY was tested using the ELISA method (2.1.7). The 
endpoint titre was converted to titre per gram of feed. 
2.3.4 Challenge strain 
A cryobead of Salmonella Typhimurium (ST12), isolated and prepared as in Section 2.1.2, 
was used as the challenge strain  The target density of 104 and 105  cfu/mL was achieved by 
decimal dilution of the colorimetrically confirmed 2 x 108 cfu/mL initial suspension (2.1.2).  
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2.3.5 Animal trials 
The trial farm was prepared as stated in Section 2.1.8. Groups of 20 chicks (non-Salmonella 
vaccinated flocks), individually identified by wing tags, were given one of three lots of feed 
formulation at one day of age and throughout the trial (15 days). On day 3 post-hatch, each 
chick was challenged (104 or 105 cfu/mL) by oral gavage (0.250 mL) with Salmonella 
Typhimurium (2.1.2). Faecal samples (n = 5) were collected from each pen on days 3 (pre-
challenge), 4, 5, 7 and 14 and cultured for the presence of S. Typhimurium (2.1.3). The birds 
were individually weighed at days 0, 7 and 14. At 15 days of age (doa), all birds were 
humanely euthanized and their caeca removed for culture and enumeration (2.1.3 and 2.3.6). 
2.3.6 Enumeration of Salmonella 
The method employed to enumerate caecal salmonellae was the miniMPN as described in 
Pavic et al., (2010). Briefly, the removed caeca were cut into sections, to which BPW (w : v) 
was added (100 dilution). A millilitre of this dilution (100) was added to a 1250 ǍL plasma 
tube and subsequent decimal serial dilutions were prepared (100 ǍL into 900 ǍL) in plasma 
tubes. 
Into appropriately labelled microtitre trays, 100 ǍL of each dilution was added into the 
corresponding well using a multi-channel pipette. This resulted in the formation of a 3-tube 
MPN, which was covered with a plastic film (SealPlate®, Excel Scientific, Inc, Victorville, 
CA, US) and incubated at 37 ºC for 24 h. Post-incubation, 100 ǍL from each microtitre well 
was added to 200 ǍL of modified semi-solid RV (MSRV) via a multi-channel pipette and 
incubated at 42 ºC 24 h.  
All pale/white wells post incubation was confirmed using SM®ID2 and typical colonies were 
confirmed serologically with Poly O, poly H and anti-serogroup B antisera. The confirmed 
data set was converted to cfu/mL, using the MPN charts produced by the United States 
FDA (2006) from the 3 lowest positive dilutions, and calculated to MPN (cfu) per gram of 
caeca. 
3. Results 
3.1 Vaccine trial 
3.1.1 Autologous (experiment 1) and heterologous (experiment 2) challenge trials 
A challenge with S. Typhimurium, used in Experiments 1 and 2 (Table 2) to demonstrate 
repeatability, showed a significant difference (Mantel-Haenszel Stratified Chi squared P < 
0.05) between non-vaccinated (colonisation rates of 25% and 50%) and vaccinated 
(colonisation rates of 0% and 9%) hens. S. Typhimurium was also used in both experiments 
to evaluate seroconversion to the Typhimurium component of the vaccine (Table 4 and 5). 
The vaccinated flocks exhibited significantly higher (Student t-test P < 0.05) titres, with 16% 
and 33% of blood samples having titres 85-6570 (>785 = kit positive threshold), while non-
vaccinated hens gave titres of 27-176 (<460 = kit negative threshold).  
After challenge, the rates of caecal colonisation (Table 2) in the non-vaccinated hens were 
25%, 58% and 17% for serovars Typhimurium, Mbandaka and Orion respectively 
(Experiment 1), with an average colonisation rate of 33%. In the heterologous trial 
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(Experiment 2) non-vaccinated hens had an average caecal colonisation rate of 42% 
calculated from the individual caecal colonisation rates: Typhimurium (50%); Agona (92%); 
Infantis (17%) and Zanzibar (9%). 
 
Experiment 
number 
Vaccine 
status 
Detected Not detected Relative risk Positive (%) 
(a) Typhimurium     
1 
Vaccinated 
Non-
vaccinated 
0 
3 
12 
9 
 
undefined 
0 
25 
2 
Vaccinated 
Non-
vaccinated 
1 
6 
10 
6 
 
0.18 
9 
50 
M-H analysis Crude OR = 0.08; 95% CI = 0 to 0.69; OR = 0.06; Χ2 = 5.73; P = 0.017  
(b) Autologous Typhimurium and heterologous Agona [B]   
2 
Vaccinated 
Non-
vaccinated 
1 
6 
10 
6 
 
0.18 
9 
50 
2 
Vaccinated 
Non-
vaccinated 
5 
11 
7 
1 
 
0.23 
42 
92 
M-H analysis 
Crude OR = 0.15; 95% CI = 0.1 to 0.49; OR = 0.08; Χ2 = 8.83; P = 
0.003 
 
(c) Autologous Mbandaka [C] and heterologous Infantis [C]   
1 
Vaccinated 
Non-
vaccinated 
1 
7 
11 
5 
 
0.02 
8 
58 
2 
Vaccinated 
Non-
vaccinated 
0 
2 
10 
10 
 
Undefined 
0 
17 
M-H analysis 
Crude OR = 0.08; 95% CI = 0.01 to 0.62; OR = 0.05; Χ2 = 6.24; P = 
0.013 
 
(d) Autologous Orion [E] and heterologous Zanzibar [E]   
1 
Vaccinated 
Non-
vaccinated 
0 
2 
12 
10 
 
Undefined 
0 
25 
2 
Vaccinated 
Non-
vaccinated 
0 
1 
10 
10 
 
Undefined 
9 
50 
M-H analysis Crude OR = 0; 95% CI = -; OR = undefined; Χ2 = 1.31; P = 0.25,   
 All remaining hens were used as negative controls.  
Table 2. Mantel-Haenszel stratified contingency table analysis of Salmonella caecal culture 
results comparing non-vaccinated and Tri-valent vaccinated Cobb™ adult breeder hens 
challenged (107 cfu / mL) with serovar (CI = confidence Interval; M-H = Mantel-Haenszel; 
OR = odds ratio). 
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The cloacal swab results (Table 3) suggested that no hens were colonised by Salmonella prior 
to challenge (Day 0). Three days post challenge (Day 3) the prevalence in non-vaccinated 
hens ranged from zero to 40 % compared to zero to 10 % for the vaccinated flocks, changing 
to 0-83 % and 0-36 % respectively 14 days post-challenge. The cloacal swabs (Table 3) 
showed that the serovar Agona colonised non-vaccinated hens the best, with prevalence of 
40 % (at day 3) and 83 % (at day 14), and a caecal prevalence of 92 %. In contrast, Zanzibar 
did not appear to colonise (day 3 and 14), based on cloacal swabs, and a caecal prevalence of 
only 9%. 
Due to low colonisation rates (17 % and 9 %), combined with the low number of replicates (n 
= 12 and 11), statistically valid (P ≤ 0.05) results could not be obtained for serogroup E 
(Table 2d). The null hypothesis could not be rejected. The statistically desired colonisation 
rate for non-vaccinated (50 %) was only achieved with serovars Mbandaka (Table 2c), 
Typhimurium and Agona (Table 2b) which all demonstrated a significant difference 
between vaccinated and non-vaccinated hens.  
By using a stratified Mantal-Haenszal Chi squared test, comparing autologous to 
heterologous serovars within the same serogroup, significant differences (P = 0.003 and 0.01) 
were demonstrated for serogroups B (Table 2b) and C (Table 2c), and respective odds ratios 
of 6.6 and 12.5 times for colonisation among non-vaccinated compared with vaccinated 
groups. However, serogroup E serovars did not demonstrate a significant difference due to 
the low colonisation rate of the non-vaccinated hens.  
The serovar Typhimurium was used to demonstrate (Table 2a) a repeatable significant 
difference between non-vaccinated and vaccinated hens (Mantel-Haenszal P = 0.017). All 
non-challenged controls were negative for the challenge and wild serovars of Salmonella. 
 
  
Prevalence of vaccinated (n =12)  / non-vaccinated (n = 12) hens at various 
days post challenge. 
      
Exp serotype Day 0  Day 3 Day 14 Day 21 caeca 
      
      
1 Typhimurium 0% / 0% 0% / 16%  0%  / 16% 0 % / 25% 
1 Mbandaka 0%  / 0% 0% / 16% 0% /16 % 8 % / 58 % 
1 Orion 0% / 0% 0% / 16% 0% / 16% 0% / 16% 
2 Typhimurium 0% / 0% 8% / 25% 9% (11) / 25% 9% (11) / 50% 
2 Agona 0% / 0% 10% /40% 36% / 83% 42% / 92% 
2 Infantis 0%  / 0% 0%  / 20% 0% (10) / 8% 0% (10) / 17% 
2 Zanzibar 0% (10) / 0%(11) 0% (10) / 0% (11) 0% (10) / 0% (11) 0% (10) / 9% (11) 
Prevalence without bracketed numerals were calculated from n = 12 as compared to n = (x). All groups 
initially contained 12 birds and bird death was due to non-trial related illness. 
Table 3. Salmonella serovars prevalence from cloacal swabs (0, 3 and 14 days) and caeca (21 
days) post challenge (107 cfu) from adult Cobb™ breeder broiler hens in Experiments 1  
and 2. 
3.1.2 Experiment 1 autologous serology 
The blood samples taken from all hens prior to challenge demonstrated that vaccinated hens 
contained variable levels of antibodies to Salmonella. This is illustrated by the wide range of 
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titres (1161  ±  623 at the 95 % confidence intervals from mean) from the x-OVO Guildhay 
Salmonella Typhimurium ELISA test (Table 4). All the unvaccinated flocks had titres well 
below the negative cutoff value. Blood samples from tri-vaccine vaccinated hens (n = 30) 
were tested, using the x-OVO Guildhay Typhimurium and Idexx Typhimurium-Infantis-
Enteritidis ELISA, showing a 1 : 0.8 ratio respectively (x-OVO Guildhay Typhimurium 
ELISA average OD = 0.39 and Idexx Typhimurium: Infantis: Enteritidis ELISA average OD 
= 0.70 in positive wells), which was highly significant (Student t-test P = 0.0001). All blood 
sera positive for anti-Infantis antibodies contained anti-Typhimurium antibodies. 
 
Blood serum result 
Typhimurium titre mean 
(95% confidence limits) 
Coefficient of variation 
Non Vaccinated titre (n = 50) 130 (± 27) 60 % 
Vaccinated titre (n = 50) 1161 (± 623)A 127 % 
A Means without common superscripts differ significantly (Student t-test <0.05). 
Table 4. Anti-Salmonella Typhimurium antibody titres means, with 95% confidence limits, 
for vaccinated and non-vaccinated Cobb™ adult breeder hens (Experiment 1). 
The large co-efficient of variation reflects variation in seroconversion among the vaccinated 
birds, with 16% of those vaccinated demonstrating titres > 785 and 25% with titres > 460 
(true negative). There was a statistically significant difference (Student’s two-tailed t-test, P 
< 0.05) in anti-Salmonella antibody levels between vaccinated and non-vaccinated flocks. 
3.1.3 Experiment 2 heterologous serology 
Half of the vaccinated group in Experiment 2 were individually tagged and bled prior to 
vaccination at 12 and 17 weeks of age (Table 5). Hens at 18 weeks had developed significant 
(Fisher exact P = 0.001) serum antibodies to S. Typhimurium compared to hens prior to 
vaccination (12 weeks), but not to hens in other age groups. Hens at 20 weeks of age had 
developed a significant difference in antibody to all age groups (P = 0.0005 and 0.01) with 
the exception of 18 week olds.  
 
Hen Age (weeks) Titre <785 Titre >785 Total Positive (%) 
12 25 0 25 0 % A 
14 22 2 24 8.33 % AB 
16 22 2 24 8.33 % AB 
18 17 6 23 26 % BC 
20 14 9 23 43 % C 
AB Percentages without common superscripts differ significantly (Fisher Exact P  <  0.05). Mortalities of 
hens at 14 and 18 weeks were due to non vaccine-related causes (Femoral Head Necrosis).  
Table 5. Anti-Salmonella Typhimurium antibody titres in vaccinated hens (n = 25) prior to (12 
weeks), during (12 to 17 weeks) and after (18 to 20 weeks) the vaccination protocol 
(Experiment 2). 
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After the first vaccination, initial sero-conversion was observed in two (8.33 %) of the hens 
(n = 24). Unfortunately, one of those hens died at 18 weeks, whereas the other hen had titres 
of 812, 1222, 1200 and 1114 at weeks 14, 16, 18 and 20 respectively, and this hen was also 
negative for presence of Salmonella in its caeca post-challenge. The percentage ‘true’ (titre > 
785) positive was 26 % or 34 % if the ELISA (2.1.7) kits ‘suspect’ interpretations were 
included. When these hens were randomised and challenged at 20 weeks of age the 
percentage of serum positive birds was 43 %, or 60 %, including ‘suspect’ reactions. The titre 
range in the second experiment was more precise with a mean titre of 1016 ± 546(95 % CI) 
and a low co-efficient of variation (26 %). 
The percentage of eggs that had antibodies against S. Typhimurium was 16 % (titre > 785), 
or 48 % (n = 61) if ‘suspects’ (titre 460 to 784) were included. Titres ranged from 145 to 1890 
for egg yolks from vaccinated hens compared with a range of 332 to 427 (below ELISA kit 
negative < 460) for non-vaccinated hens eggs. Regardless of the low number of ELISA 
positives (titres > 785) from eggs originating from vaccinated hens, there was still a 
significant difference (P = 0.001) between egg yolk anti-Typhimurium titres from non-
vaccinated as compared to vaccinated hens.  
3.1.4 Maternal antibody protection (experiment 3) 
All chicks (except non-vaccinated and non challenged control and vaccinated non-
challenged control) were challenged at day 0 and appeared healthy and gained weight.  
Initial serological testing from a culled group (n = 24) resulted in negative titres (< 460) and 
chick paper culture was negative for Salmonella for both non-vaccinated and vaccinated 
flocks. There was one chick from the vaccinated 108 and non-vaccinated 104 (Table 6) which 
died from conditions unrelated to the trial (Femoral Head Necrosis).  
 
Groups 21 day old caecal Salmonella 
Vaccine status /  challenge level Detected Not detected 
AVaccinated / 108 cfu 19 0 
ANon-vaccinated / 108 cfu 20 0 
BVaccinated / 104 cfu 15 5 
ANon-vaccinated / 104 cfu 19 0 
The vaccinated / non challenged (n = 10) and non-vaccinated / non challenged (n = 10) controls were 
all negative for Salmonella. Groups without common superscripts differ significantly (Fisher Exact P  ≤  
0.05). One chick died from a non-trial related cause (Femoral Head Necrosis) in both the vaccinated 108 
and non-vaccinated 104 group. There were no differences between cloacal swab results from days 3, 14 
and 21. 
Table 6. Salmonella vaccinated (n = 50) and non-vaccinated (n = 50) progeny protection from 
S. Typhimurium challenge at high (108 cfu) and low (104 cfu) dose. 
The cloacal swab results from randomly chosen chicks (n = 5) were all positive 3 days post 
challenge for S. Typhimurium, during the grow-out phase (day 14 swabs) and caecal culture 
results (day 24) when the birds were challenged with 108 cfu Salmonella.  
The cloacal swabs and caecal cultures revealed a significant difference (Fisher exact P  =  
0.047) between chicks challenged with 104 cfu of S. Typhimurium, which were progeny, of 
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vaccinated hens (75% positive) compared to progeny from non-vaccinated (100 % positive) 
hens at 3, 14 and 24 days of age (Table 6). The serology results, initially and at 21 days post 
challenge, indicated negative S. Typhimurium antibody titres (< 460) for both vaccinated 
and non-vaccinated chicks. 
3.1.5 Longitudinal analysis 
The comparison of the prevalence of Salmonella, at genus level and within flocks, was 
performed by plotting the monthly drag swab relative prevalence (positive flocks / total 
flocks tested in each month) one year prior to vaccination (2003), during vaccination (2004) 
and subsequent vaccination (2005).  
The prevalence of Salmonella in 2003 was 52 %, decreasing to 41 % in 2004 and 40 % in 2005 
(Figures 1 and 2). The first flocks vaccinated were 12 weeks of age as of the 1/1/2004, 
designated with an arrow (Figure 1). For each month post vaccination the ‘forecast’ relative 
prevalence (Figure 1) was calculated (Excel, forecast function using the previous 12 months 
prevalence data to calculate the predicted value). 
The year prior to vaccination (Figure 1) showed peaks and troughs in flock prevalence, 
which followed seasons (lowest prevalence in winter and higher prevalence in summer). As 
the flocks were vaccinated, the monthly prevalence levels decreased and the monthly 
variation flattened; a moderate linear association (R2 = 0.56) was found, compared to 
‘forecast’ values (R2 = 0.16) (Figure 1). 
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Fig. 1. Salmonella flock monthly prevalence (%) in Breeders during the years 2003 (n = 794) to 
2004 (n = 1024) with the arrow indicating when vaccination started and forecast data (Red 
line) used to show the predicted prevalence if vaccination was not introduced. 
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Fig. 2. Salmonella flock monthly prevalence (%) in Breeders during the vaccinations years 
2004 (n = 1024) to 2005 (n = 968). The two arrows indicate the start of vaccination and the 
month when all flocks were vaccinated. 
 
Fig. 3. The prevalence rate in tri-valent vaccine-relevant serogroups in breeders, based upon 
flock age for the pre-vaccinated year 2003 (n = 794) and the vaccinated years 2004 (n = 1024) 
and 2005 (n = 968) with vaccination occurring at 12 and 18 weeks of age. 
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The variation in sample size, 794 (2003), 1024 (2004) and 968 (2005), was due to more 
intensive testing in the first year of vaccination. The flock prevalence rate between 2004 (40 
%) and 2005 (41 %) remained static, which was corroborated by a R2 (linear) of almost zero 
(Figure 2). The spikes observed in the latter half of 2005 (Figure 2) were due to the 
unplanned introduction of non-vaccinated Salmonella-positive males, at 20 weeks of age, to 
other breeder farms.  
The results in Figure 3 demonstrate an interesting trend in the prevalence for the years in 
which the vaccine e was administered (2004 and 2005, blue and green bars) compared to the 
year prior (2003, red bar). The prevalence of Salmonella from serogroups B, C and E 
decreased post-vaccination while increases among non-vaccine serogroups were observed, 
with serovar subsp 1 rough:r:1,5 predominating (Table 7). 
 
   Year  
sero-group Serovar 2003 2004 2005 
     
B Agona 15.0% 6.0% 5.8% 
B Subsp 1 ser 4,12:d:- 5.5% 8.0% 0.4% 
B Typhimurium 15.2% 7.2% 9.03% 
C1 Infantis 29.2% 26.0% 18.6% 
C1 Livingstone 6.1% 0.5% 0.21% 
C1 Mbandaka 4.9% 6.0% 6.6% 
C1 Singapore 0.6% 0.9% 0.24% 
C2 Bovismorbificans 12.6% 3.3% 3.61% 
C2 Muenchen 0.6% 0.23% 1.51% 
E1 Orion 2.2% 0.23% 0.4% 
E1 Zanzibar 3.8% 5.2% 6.2% 
E4 Seftenberg 0.6 2.0% 4.7% 
 Subsp 1 ser rough:r:1,5 0.6% 23% 14.6% 
 percentage total 97.0% 88.56% 71.9% 
 total positive flocks 412 420 387 
Table 7. Flock Salmonella serovar trend for the year prior, 2003 (n = 794), and the years post-
vaccination, 2004 (n = 1024) and 2005 (n = 968).  
During and subsequent to vaccination there was a change in the profile of serovars isolated 
from breeder flocks (Table 7). The vaccine serogroups all decreased with the exception of 
Mbandaka (serogroup C). This increase could be explained by early colonisation prior to 
vaccination (Figure 4). Table 7 shows serovar succession, which may have occurred post 
vaccination.  
Prior to vaccination (2003) there were 13 serovars that accounted for 97 % of all positives 
(Table 7). This figure decreased to 88.9 % (2004) and 71.9 % (2005) when all flocks were 
vaccinated. There was also a major change in the predominant serovar with rough: r: 1:5 
increasing from 0.6 % (2003) to 23 % (2004) and 14.6 % (2005), both significantly different (χ2 
P = 0.0001). Beside those in Table 7, the serovars isolated were: in 2003 Lille (1.2 %), Ohio 
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(0.6 %), subsp. 1 ser 16:I;v;- (0.6 %) and Tennessee (0.6 %); 2004 and 2005 Anatum (0.5 % 
{2004}, 1 % {2005}), Chester (0.6 %, 1.2 %), Give (1.6 %, 2.0 %), Havana (0.6 %, 5 %), Javiana 
(0.6 %, 1.5 %), Kiambu (1.5 %, 3 %), Lillee (1.5 %, 1 %), Ohio (1.2 %, 1.9 %), Subsps 1 ser 
16:I;v;- (1.5 %, 3.5 %), Subsps 1 ser 6,7:r:- (0.6 %, 0 %), Worthington (1.6 %, 0 %), Bredeney (0 
%, 2 %), Cubana (0 %, 3.5 %) and Tennessee (0 %, 2 %). 
There was no overall change in prevalence of serogroup C1 (Table 7); while the C1 positive 
flocks were all positive prior to vaccination at a steady 5 % prevalence rate, there was a shift 
in serovar prevalence, with a decrease in Infantis, the vaccine-homologous serovar.  
Results suggest marginal heterologous serovar protection as shown by the steady decrease 
in Agona (serogroup B) post-vaccination. This decrease was similar to that for 
Typhimurium, observed over the same time period, and may explain the reduction in total 
prevalence observed during the field trial (Figure 1).  
The seroconversion of birds to the vaccine Typhimurium component was routinely 
measured (ELISA) at the ages mentioned in Figure 4, and the mean (n = 12), with 95 % 
confidence limits, was recorded. The green (line) and the red (line) indicated the 
Typhimurium ELISA positive and negative titres levels respectively (Figure 4).  
The ELISA results (Figure 4) showed a high degree of variability in seroconversion, 
indicated by the very large error bars (95 % confidence). The level of flock immunity 
(number of sera tested that had Typhimurium ELISA titres > 785) for each age group (Figure 
4) during 2004 (2005) was 23 % (27 %); 15 % (17 %); 11 % (11 %) and 3 % (6.4 %). The average 
flock immunity for 2004 and 2005 was (titre > 785 positive level) 28 % and 27 % respectively 
or 40 % and 37 % if the titre was calculated at > 460 (negative level).  
The 2005 trend line had a dip at 23 to 32 weeks of age; only 21 flocks (272 sera) were tested 
in 2004 compared to 135 flocks (1345 serums) tested in 2005, which affected the average. This 
large discrepancy in flocks tested in this age group (2004 and 2005) was not observed in any 
other age group during the same period (2004 to 2005). 
The titre profile shown in Figure 4 for all flocks was also apparent when the titres of the 
individual flocks were examined over the same time period (categorized by weeks of 
age{woa}). They all showed a similar age titre profile (Figure 4; year 2004) with a shoulder 
period (ages 13 to 22 and 23 to 32) and then a decrease with age.  
An investigation into the efficacy of the tri-vaccine on juvenile (< 6 woa) breeder flocks 
(grown day old to death, rearing and production), already colonized by serovar 
Typhimurium (n = 32), was undertaken during 2004 to 2005. All these Typhimurium 
positive flocks (determined using drag swabs) were routinely sampled, as mentioned 
previously, and the drag swabs were compared to the anti-Typhimurium titre for the same 
age groups. A flock was deemed negative if two consecutive drag swabs did not contain the 
Typhimurium serovar, and the initial age recorded (i.e. 6 woa = Typhimurium positive; 12 
woa = positive; 18 woa = positive; 22 woa = positive; 33 woa = negative; 43 woa = negative 
and 53 woa = negative, the age negative is 33 woa).  
The corresponding Typhimurium titre was also measured and the flock average over the 
sampling period was recorded. The data summarized in Figure 5 show a random and 
variable Typhimurium clearance rate in flocks with low (< 1000) anti-Typhimurium 
antibody means, with only two flocks clearing the serovar prior to production age (> 25 
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Fig. 4. Flock seroconversion of the Typhimurium component (positive {green line} and 
negative {red line} ELISA thresholds) of the Tri-vaccine as measure by anti-Typhimurium 
ELISA (95 % confidence limits) from flock (n = 12) bloods taken at various ages between 
2004 and 2005. 
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Fig. 5. Naturally Typhimurium colonised chicks (2004 to 2005), grown in day old to death 
houses, clearance age (weeks) in relation to the flock mean (n = 12) anti-Typhimurium titre 
trend (exponential R2), measured post vaccination (12 and 18 weeks), with critical limits set 
at hen age of 25 weeks (green line) and mean titre > 1000 (blue line).  
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woa). Six of seven flocks with high titre (> 1000) were clear of Typhimurium at production 
age (< 25 woa). These flocks with high titre means (> 1000) also had high (75 %, n =12) flock 
immunity (anti-Typhimurium titre > 850). 
The data in Figure 5 were analyzed using an exponential trend line, which showed a 
moderate association (R2 = 0.45) that, when converted to a 2 x 2 contingency table (Table 8), 
was highly significant (χ2 P = 0.0002) between titre and Typhimurium clearance. 
Additionally, Typhimurium colonized flocks were 17.5 times more likely to remain 
colonized after 25 woa, if their titres were below 1000.  
 
Typhimurium titre Negative at < 25 Positive at  >26 Total 
High >1000 6 1 7 
Low <1000 2 23 25 
total 8 24 32 
Fisher exact P = 0.0002 with an odds ratio of 140 and a relative risk of 17.5. 
Table 8. The Chi squared analysis comparing high (> 1000) and low (< 1000) mean (n = 12) 
anti-Typhimurium titres in pre-vaccinated Typhimurium positive flocks that had 
consecutive negative drag swabs at 25 weeks of age. 
3.2 Immunoprophylaxis trial 
3.2.1 IgY analysis 
ELISA analysis of the breeder egg yolks from three different farms showed that all the flocks 
had high flock immunity (number of samples titre > 785 in serum sample divided by total 
tested) and a high mean flock titre (Table 9). The crude IgY yield (Figure 6) ELISA results 
(Figure 7) showed a high variance in Typhimurium antibodies (15 % to 80 % > 785 and 
means of 343 to 2518) deposited in egg yolks tested (n = 20) which was further investigated 
using Farm 1 yolks (Figure 8).  
 
 
 Farm 1 Farm 2 Farm 3 
    
Flock Typhimurium serum (IgY)  
mean (95% CI) 
 
1118 (+502) 
 
1844 (+528) 
 
2104 (+564) 
Flock Immunity rate 70 % 85 % 100 % 
Egg Typhimurium IgY positive rate 15 % 26 % 80  % 
Egg Typhimurium IgY titre mean (95% CI) 343 (+143) 761 (+276) 2518 (+1361) 
Crude IgY yield mg/g yolk (95% CI) 28  (+8) 32  (+12) 26    (+4) 
Crude Typhimurium IgY mean (95% CI) titre 153 (+118) 386 (+286) 690   (+390) 
 
Table 9. Summary of Salmonella Typhimurium vaccinated donor flocks for mean (95% CI) 
antibody titres, from serum (n = 12), egg yolk (n = 20) and crude extract (n = 20), flock 
immunity (percentage of sera with titre > 785), yolk positive rate (No. of yolks > 785 titre) 
and crude IgY yield (mg/g).  
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Fig. 6. Salt precipitated crude IgY containing Typhimurium antibodies, which were 
extracted from vaccinated breeder hen’s eggs. 
 
Fig. 7. Salmonella Typhimurium ELISA plate, using doubling dilution, to determine the 
crude IgY titre from egg yolk extract.  
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Fig. 8. Variability in anti-Typhimurium ELISA (positive > 785, green line, and negative < 
459, red line) titre means (n = 8, 95 % CI) in eggs (n = 20) from Farm 1. The data portrayed in 
Figure 8 show a very large variance in the Typhimurium antibody levels present in Farm 1 
egg yolks. Only egg yolks 4, 8 and 19 had Typhimurium titres levels close to the ELISA 
positive range of > 785. The majority of yolks, with the exception of yolks 1, 5 and 15, were 
below the negative level of < 459.  
Of the yolks from the three farms, composited post-freeze drying, anti-Typhimurium 
antibodies (titre > 785) were present in 90 % of the samples tested. The titres in the 
composites ranged from 16 to 1024 with a mean (+ 95 % CI) of 386 (+ 203). The egg yolk 
composited crude extract (Figure 7) resuspended in PBS (5 mL per yolk), had an IgY titre of 
256. 
3.2.2 IgY feed trial 
The results of the net body weight gain for these four feeding regimes are summarised in 
Figure 9 which showed that there was no significant difference (Student t-test > 0.05) for all 
the feeds regardless of Typhimurium challenge dose and at various ages (0, 7, and 14 doa).  
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Fig. 9. The net body weight gain (after 15 days) of challenged (104 or 105 cfu/mL of S. 
typhimurium) chicks fed with four rations. 
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The rehydrated dT-IgY was fed to the chicks initially by hand (smearing of dT-IgY paste on 
the beak) with the remainder of the feed spread out in a line on chick paper. Only when all 
this feed was consumed was the standard ration introduced. This ensured that all the 
rehydrated dT-IgY was consumed.  
The residual treated feed was tested for the presence of Typhimurium antibody. The results, 
summarised in Figure 10, show that the chicks in the treatment groups received anti-
Typhimurium IgY, in various degrees, throughout the trial. 
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Fig. 10. Typhimurium antibody titre (95% CI) of three treated feed rations: (CF) plus 3% 
(w:w) freeze dried Typhimurium IgY (dt-IgY) yolk (green line); CF plus dT-IgY 
resuspended in water (w:v) (red line) and dT-IgY resuspended in crude Typhimurium IgY 
extract (w:v) (blue line) feed prior (3 days) and post (4 days of age+) Typhimurium (104 or 
105 cfu/mL) challenge. 
The data summarised in Figure 10 showed that the dT-IgY resuspended in crude IgY extract 
(blue line) had the highest and most consistent titres, with a range 80 to 160 and a mean of 
110, throughout the trial. The dT-IgY resuspended in water (red line) had the highest titre 
range of 50 to 130 and a mean of 60. Finally, the dT-IgY egg yolk powder (green line) 
treatment was the most inconsistent with a titre range of 0 to 150 and a low mean of 61.  
The final analysis was to measure the effect of these feed treatments on S. Typhimurium 
levels in the caeca. The data summarised in Figure 11 show that, regardless of treatment, 
there was no significant (Student t test > 0.05) reduction in caecal Typhimurium populations 
as compared to the control. This was also observed in faecal (days 4, 5, 7 and 14) and caecal 
samples that were 100 % positive when tested qualitatively for Salmonella presence. 
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Fig. 11. S. Typhimurium caecal counts (log10 cfu/g, 95 % CI) from challenged (104 or 105 
cfu/mL) chicks on three feed treatments.  
4. Discussion 
4.1 Vaccine trial 
One of the objectives behind developing and using a multivalent vaccine was to reduce 
carriage and shedding of otherwise prevalent salmonellae, and thus to protect the progeny 
from egg contamination and from colonisation by low level (< 100 cfu) environmental and / 
or feed exposure (Anonymous, 2004; Franco, 2005; Volkova et al., 2009). The protection of 
poultry against Salmonella infection is largely empirical, based upon experimental trial work 
and field studies (Anonymous, 2004). Knowledge relating to the course of the innate and 
adaptive response to colonisation with various Salmonella types is beginning to increase 
(Anonymous 2004; Beal and Smith 2007). To be suitable for use in industry, a vaccine must 
be safe for poultry and other species, and not interfere with detection of Salmonella, as well 
as effective in eliminating shedding and enhancing clearance (Anonymous 2004).  
With the above definition in mind the decision to use the predominant serovar from each of 
serogroups B, C and E was based upon success of this approach with serovars 
Typhimurium and Enteritidis in a European study (Van Den Bosch 2003), and serogroups C 
and E were added primarily to offer protection against the prominent Australian poultry 
serogroups (Davos, 2005) and, secondarily, to expand the knowledge base (Anonymous, 
2004,). There were no serovars from serogroup D included in this vaccine as Australian 
commercial flocks are free of this serogroup (due to zero tolerance), including serovars 
Enteritidis, Pullorum and Gallinarum (Arzey, 2005).  
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According to Grimont and Weill (2007) only 30 serovars account for 90 % of Salmonella 
isolates in any given country. In the Australian broiler industry, typically ten different 
serovars account for 84 % of all isolates (Davos, 2007). To suit inevitable changes in serovar 
prevalence, killed vaccines such as the trivaccine in the present study are most suitable for 
industrial use as they can be more easily prepared and therefore more readily adapted than 
attenuated strain vaccines.  
Prior to 2008, due to consumer fears about genetically modified organisms (GMOs), in the 
food supply, only killed Salmonella vaccines were available for commercial use in Australia 
(Anonymous, 1999). The next stage of development would include vaccination with killed 
and attenuated Salmonellae to target both cell mediated and humoral immunity.  
Bailey et al. (2007a) showed increased IgG and IgA production in serum, the gut and crop of 
adult broiler breeders after administered of a live followed by a killed vaccine, when 
compared to a killed or attenuated vaccine alone. Attenuated vaccines can be given to day-
old chicks, providing competitive exclusion and stimulating polymorphonucleated cell 
migration to the intestinal cell walls, thus preventing initial colonisation by wild strains 
(Van Immerseel et al., 2005). 
In the present study, a killed multi-serotype vaccine was injected into hens after 12 weeks 
of age to provide humoral protection. Bailey et al. (2007a) administered an aroA attenuated 
Enteritidis vaccine at 1 and 21 days followed by an autogenous killed trivalent vaccine to 
11 and 17 week old broiler breeder parents. Following post-vaccination autologous 
challenge, the reduction in caecal counts and increase in antibody titre were similar in the 
study of Bailey et al. (2007ab) and the present study, suggesting the killed vaccine alone is 
effective.  
However, Deguchi et al. (2009) administered an autologous trivalent (Enteritidis, 
Typhimurium and Infantis) killed vaccine at only 6 weeks of age and was able to show an 
increased antibody titre and reduced caecal carriage, for challenge (109 cfu) with all 
autologous serovars. The variable results across these studies suggest that the effectiveness 
of vaccination may vary with the nature and timing of administration of the vaccine. The 
efficacy of a killed vaccine can be enhanced by using improved adjuvants that may target 
different parts of the immune system (Barrow 2007). 
The modest total colonisation rates in non-vaccinated hens of 33 % and 42 % (Experiment 1 
and 2) illustrated that the challenge dose (107 cfu) may have been too low or the strains were 
attenuated. Other studies (Byrd et al., 2003; Babu et al., 2004) showed high rates of 
colonisation (> 80%) with high challenge doses of Typhimurium (108 to 109 cfu and 1010 cfu 
respectively). However, the 107 cfu challenge dose was chosen as this is a more realistic, 
field-appropriate, natural challenge, than 1010 cfu.  
Numerous studies indicate avian susceptibility to Salmonella is not uniform and many 
influencing factors exist. The literature suggests that a stable anaerobic microflora, low 
house density, bacterial interference, breed resistance, antagonism, colonisation resistance, 
barrier effects, challenge strain virulence, competitive exclusion and passive immunity 
could all contribute to low challenge rates (Lloyd et al., 1977; Fuller, 1989; Mead and Barrow, 
1990; Kottom et al., 1995; Duchet-Suchaux et al., 1997; Nisbet et al., 2000; Quinn et al., 2000; 
Chambers and Lu, 2002; Kinde et al., 2005).  
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The hens used in this study were derived from a field trial situation, stocked at low densities 
and were healthy, thus decreasing their susceptibility to colonisation to levels less than 
expected than under the stressful conditions of industry practices. When this vaccine was 
used under field conditions, over a four year period, the incidence of Typhimurium was 
reduced in vaccinated flocks with an anti-Typhimurium ELISA titre of > 1000 (Figure 5). 
The results summarised in Tables 2.1b and 2.1c highlight autologous and heterologous 
serotype protection conferred by the multivalent vaccine and these trial results were similar 
to those of Clifton-Hadley et al. (2002) during trial of the first Salenvac® bi-vaccine. The 
repeatability with S. Typhimurium in both trials was expected and heterologous protection 
was demonstrated with the serogroup B serotype Agona. Protection against heterologous 
serotypes from serogroup B was also demonstrated by Beal et al. (2006).  
The serovars Orion and Zanzibar (serogroup E) were both chosen due to their field 
prevalence at the time in chicken litter and meat (Davos, 2005). However, these serovars 
both failed to colonise caeca 21 days after challenge. While detection in flocks may suggest 
colonisation, such serovars may derive from the environment or feed and be transitory or 
only capable of minimal colonisation in the birds; still detectable by drag swabs of flocks. 
The x-OVO Guildhay Salmonella Typhimurium lipopolysaccharide ELISA was used in this 
study to measure the immune response to the vaccine, as it was used during development of 
the first Salenvac killed vaccine (McMullin et al., 1997). The trivaccine contains 1x108 cfu of 
each of the three serovars added in a ratio of 1:1:1.  
The assumption is that the hen develops antibodies to each serovar at titres similar to those 
determined for S. Typhimurium. Okamura et al. (2007) demonstrated similar Salmonella 
lipopolysaccharide ELISA antibody titres in hens, vaccinated with a killed bivalent vaccine 
containing serovars Enteritidis and Typhimurium.  
A comparison using the x-OVO Guildhay Typhimurium kit and a commercial swine 
Salmonella (Typhimurium, Infantis and Enteritidis) kit, at a 1:500 dilution with anti-chicken 
conjugate and substrate added to both kits and read at 550nM showed a 1:0.8 ratio, which 
was highly significant (Student t-test P  <  0.0001). While the ratio was not the theorised 1:1 
ratio, there was a consistently higher OD observed in the Idexx trivalent kit, which may be 
attributed to the presence of serogroup C1 antibodies.  
The S. Typhimurium ELISA results in experiment 1 and 2 were significantly different 
(Student t-test P = 0.001) between vaccinated and non-vaccinated hens (titre < 460) (Table 4) 
and results from this trial are very similar to the cited trials and therefore protective levels of 
antibodies have to be present in vaccinated hens caeca (Clifton-Hadley et al., 2002; Beal et al., 
2006; Okamura et al. 2007; Deguchi et al. 2009). 
As this was a new vaccine an extremely high co-efficient of variance (127 %) was observed 
in, the commercial field, vaccinated flocks used in Experiment 1. This may have been due to 
phase separation of the adjuvant and the killed cells gravity settled to the bottom of the vial. 
The repeat Experiment (2) the vaccine suspension was vigorously shaken prior to hand 
vaccination under trial conditions. This resulted in a decreased co-efficient of variation in 
vaccinated hens to 26 % and a higher percentage positive (36 % >785 titre).  
Prior to Experiment 2 (heterologous challenge), all hens were sourced unvaccinated, then 
manually vaccinated at 12 and 17 weeks to measure the seroconversion rate. The data 
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summarised in Table 5 indicated seroconversion (> 785 titre) which, while slow between the 
priming dose at 12 weeks of age (8%) and the booster at 17 weeks (18 %), peaked at 43 % by 
20 weeks of age. Deguchi et al. (2009) also observed significantly high titre values four weeks 
post vaccination and McMullin et al. (1997) indicated that a minimum of 30 % of hens 
positive serologically by 22 weeks of age was required to confer flock immunity (to 
colonisation by S. Enteritidis using Salenvac vaccine and the Guildhay ELISA for S. 
Enteritidis). In the present study, 43 % of hens were seropositive (titre > 785) after 20 weeks, 
indicating flock immunity.  
The Guildhay method requires an initial serum dilution of 1:500 whereas similar work with 
killed Typhimurium used initial serum dilution of 1:250, 1:400 and 1:400 respectively (Beal et 
al., 2005; Withanage et al., 2005; Bailey et al., 2007a). The higher initial dilution rate may have 
greatly reduced the number of ELISA positives in this trial.  
In the vaccinated flock challenged with S. Typhimurium (Table 2a) the strain was recovered 
from the caeca of only one hen (n = 11) compared to six hens in the non-vaccinated group (n 
= 12). The vaccination of hens against Salmonella may aid in the decrease of Salmonella 
numbers house from the caeca, and thus decrease shell contamination, which may, in turn, 
prevent chick colonisation during hatching.  
The amount of IgY transferred to the egg yolk is proportional to maternal serum IgG 
concentrations (Loeken and Roth, 1983; Al-Natour et al., 2004; Hamal et al., 2006). The 
transfer of circulating anti-Salmonellae antibody (IgG) into egg yolk (IgY), was demonstrated 
by Chalghoumi et al. (2008) and Bailey et al. (2007a), after vaccination with serovars 
Enteritidis and Typhimurium.  
Therefore, it is expected that antibodies against the three vaccine strains used in this study 
would have been transferred to the yolk. In the present study, the detection of serovar 
Typhimurium antibodies (titre > 785) were measured in 16 % of egg yolks, and 52 % 
contained no Typhimurium antibody (titre < 460). In addition, 32 % of yolks gave titres that 
were in the ‘suspect’ range for the ELISA (460 to 784).  
The data suggest maternal transfer of IgY of Typhimurium antibodies from vaccinated hens. 
The level of detection in this study was 16 % (> 760) or 48 % (> 460) and was similar to the 
30 % achieved in a previous study (Hamal et al., 2006).  
The variable level of titre measured in egg yolk may be an artefact from initial dilution 
(1:500), as discussed previously, especially when compared to the study of Hassan and 
Curtiss (1996) egg yolk dilution of 1:100. The titres of anti-Salmonella antibody in this study 
ranged from 538-1784 and 145-1890 in serum and yolk respectively (at the 95th percentile), 
indicating that sero-conversion was not uniform among hens.  
Therefore, low level of circulating antibody would likely result in transfer of a low level of 
antibody into the egg yolk. Also, as the eggs were sampled from pens and not individual 
hens, only broad comparisons could be made. The presence of anti-Typhimurium IgY in egg 
yolk from vaccinated hens was not observed as increased anti-Typhimurium IgG in their 
serum of their progeny.  
The final experiment (Experiment 3) measured the effects of maternal anti-Salmonella 
antibodies in day-old chicks, challenged with different doses of S. Typhimurium. Reduction 
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in colonisation by S. Typhimurium is problematic, even in vaccinated chicks. While good 
reduction has been observed when chicks are challenged with 104 cfu, reduction is poor at 
higher challenge doses (106 and 108 cfu; Nisbet et al., 2000; Clifton-Hadley et al., 2002).  
Methner et al. (1999) showed a 0.5-1.5 log10 cfu reduction in carriage in vaccinated chicks 
challenged with variable populations of S. Typhimurium. Bailey, et al. (2007b) showed a 0.5 
log10 reduction in day old progeny from vaccinated hens, challenged with 107 cfu, which 
may be due to maternal IgY. 
In the present experiment, in vaccinated chicks, a 25 % clearance from caeca was observed in 
chicks challenged with 104 cfu, while no reduction was evident using a 108 cfu challenge 
(Table 6), indicating a limit to protection by maternal antibodies. 
The literature showed conflicting results with respect to maternal antibody protection 
against Salmonella colonisation; Hassan and Curtiss (1996) showed protection whereas 
Bailey et al. (2007b) showed no protection. There is a need for more experimental work in 
this area using standardised ELISA, challenge and measurement techniques.  
Regardless of challenge dose, Nisbet et al. (2000) showed a 2 log10 reduction in Salmonella 
establishing in the caeca whereas Clifton-Hadley et al. (2002) suggested that high challenge 
doses of highly invasive and virulent S. Typhimurium may overcome those components of 
the immune system associated with the systemic phase of infection. Therefore, the 104 cfu 
challenge is the minimum dosage that will not overwhelm the immune system and still 
results in colonisation of non-vaccinated controls.  
Based on the results of this study, vaccination of all breeder flocks by several Australian 
commercial broiler growers was introduced as an adjunct to other Salmonella control 
measures. The effectiveness of this vaccine in the field was tested using routine monitoring 
data, for blood and drag swabs for weeks 6, 14, 18, 22, 33, 43, 53 for the year prior (2003) to 
vaccination, during vaccination (2004) and post vaccination (2005). The results showed an 
overall decrease in flock prevalence from 51% (2003) to 40 % and 41 % (2004 and 2005 
respectively) which, while not statistically significant (χ2 P = >0.05), was an important 
reduction. The comprehensive risk assessment produced by the FAO/WHO (2002) stated 
that ”there was a one to one relationship (assuming that everything else remains constant) 
between percentage change in prevalence to expected risk of illness”. The example cited by 
the FAO/WHO (2002) stated that if prevalence reduced from 20 % to 10 %, this would result 
in a similar 50 % reduction of risk in illness per serving.  
The reduction in flock prevalence was noticed across all flock ages (Figure 3) with a 
reduction in chick (<12 woa) prevalence, which may be attributed to maternal tri-vaccine 
antibody (Hassan and Curtiss, 1996). The increase in Salmonella prevalence during weeks 13 
to 22 may be due to the hen sexual maturity, which may be associated with a situation akin 
to the peri-parturient relaxation of resistance (Kelly, 1973) seen in mammals.  
This condition is contributory to susceptibility of sheep to parasite infection after birth and 
has been attributed to the release of prolactin (Kelly, 1973). Hens also produce prolactin, 
initiating broodiness, which may limit early egg production and may increase their 
susceptibility to Salmonella colonisation (Leboucher et al., 1990; Talbot et al., 1991; March, et 
al., 1994; Berry, 2003).  
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The increase in flock prevalence of Salmonellae in that age bracket (13 to 22 weeks) may also 
be due to the introduction of males from other rearing houses. These males were not 
vaccinated and may have been a source of Salmonella. 
There was a decrease in Salmonella prevalence post-vaccination, (2004-2005) across all age 
groups, for serogroups B and C but not for serogorup E (Figure 3 and Table 7). The flock 
horizontal data are very similar to the observations noticed in the trial (Table 2) and support 
the hypothesis that serogroup E is transitory and does not persistently colonise the avian 
intestinal tract.  
There was also a change in Salmonella serovar profile (Table 7), with 13 serovars in 2003 
accounting for 97 % of all flock isolates. When these same serovars were tracked through the 
vaccination years (2004 to 2005) they accounted for only 88.6 % and 71.9 % respectively. The 
biggest change in prevalence was observed in the non-vaccine serovars Senftenberg 
(serogroup E4) from 0.6 % in 2003 to 4.7 % in 2005 and subsp. 1 ser rough:r:1,5 from 0.6 % to 
14.6 % for the same time period (Figure 3 and Table 7).  
The serovar changes observed may have been introduction through feed, litter, vermin, and 
equipment (FAO/WHO, 2002; Arsenault et al., 2007). The presence of this rough:r:1, 5 
serovar has identical flagellar antigens to Infantis, suggesting these isolates are variants of 
that serovar. The term “rough” means that this Salmonella is devoid of somatic antigens 
(lipopolysaccharide). However, its flagellar antigenic structure is very similar to that of 
serovar Infantis (Davos, personal communication).  
According to the complete Le Minor-White-Kauffman scheme there are 11 other serovars 
that have the same flagellar structure: Bradford (serogroup [B]); Czernyring [054]; 
Abertbanju [V]; Lubumbashi [S]; Hindmarsh [C2-C3]; Linde [P]; Jamaica [D1]; Ughelli [E1]; 
Senegal [F]; Tennenlohe [K] and Gege [N] (Grimont and Weill, 2007). However, none of 
these serovars have been isolated in Australia (Davos, 2008) thus supporting the initial 
hypothesis that this rough strain is a variant of Infantis. 
The flock seroconversion of the Typhimurium component was measured and reported in 
Figure 4. The annual (2004 and 2005) flock positive (> 785) titre rates (flock immunity) were 
28 % and 27 % respectively, with peak rates recorded between 13 and 22 woa. These figures 
were less than the trial figure of 43 % at 20 woa and slightly lower than the 30 % 
seroconversion described by McMullin et al. (1997). This may be due to difficultly in hand 
vaccinating thousands of hens per day (shown by the wide 95 % confidence range) and the 
stress placed upon the hen which may act as an immunosuppressant and compromise 
seroconversion (Shini et al., 2010). 
The data summarised in Figure 5 suggest that a high average titre (> 1000 mean) may aid in 
reduced shedding of serovar Typhimurium within the flock. This may be due to the 
increased production of IgY and IgA within the gut of the hen (Bailey et al., 2007a). The 
mean titre of 1000 was chosen as its S/P ratio was 0.35 which was 0.1 larger than the cut-off 
positive S/P ratio of 0.25. The cut off age of 25 weeks was chosen as that is approximately 
the age when the hens are in full fertile egg production.  
An interesting observation was seen on a day old to death (Aug to Jun) farm with six houses 
(flocks) on which all were colonised with Typhimurium prior to vaccination. The flock in 
the fourth house had a high mean titre (2566 and 75 % flock immunity) and was clear of 
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Typhimurium colonisation at 23, 33 and 43 woa (no 53 woa swabs taken) whereas the 
adjoining flocks in houses three and five, with low titres (266 and 786 respectively), were 
still positive for Typhimurium after 33 and 43 weeks.  
In another State, a four-house day old to death (Oct to Sep) complex had the first house with 
a high mean titre (1246) and was negative for Typhimurium after 25 weeks whereas the 
adjoining three houses with low titres (426, 828 and 533) were positive after 25 weeks. More 
controlled research is required to understand the factors contributing to clearance.  
As these flocks were on the same farm and the adjoining houses were positive, then it may 
be safe to assume that the feed and water were Salmonella free and biosecurity prevented 
cross-contamination. However, both of these farms had relatively young flocks over the 
Australian summer (Nov to Feb). These poultry farms have curtained sides, and the 
presence of flies is very high. Flies are known carriers of Salmonella (Wales et al., 2010) and 
could continuously reinfect the flocks, therefore limiting the effectiveness of biosercurity in 
preventing Salmonella colonisation and spread.  
Another possible explanation is that the isolation of Salmonella using a drag swab may 
favour the dominant serovar within the flock and the sub-dominant serovars may be 
masked or have a lower probability of detection. However, this error should be consistent 
throughout the farm and a reduced number of Typhimurium would also mean a reduced 
risk as mentioned previously. 
The two most consistent observations are that both these flocks, in different locations and 
States, had high (> 1000) Typhimurium titres; as Occam’s (or Ockham’s) Razor states, “with 
all things being equal the simplest solution is often the correct one” (Anonymous, 2010). 
Therefore high titre and flock immunity is very important in clearance of Typhimurium. 
One of the problems associated with horizontal field trials is the absence of contemporary 
controls. Therefore, assumptions are made that all growing conditions, feed, water supply 
and management are the same (constant variable), with vaccination (controlled variable) 
and Salmonella exposure (uncontrolled variable) the measured variables. Unfortunately, 
when using commercial broiler flocks, in real world situations, as the time frame increases 
so too does the possibility that flock management practices may change due to flock illness 
or economic necessities thus altering crucial parameters. Therefore, any conclusions made 
from historical data need to be guarded and very general. 
In conclusion, the vaccination of Cobb™ breeders with an autologous vaccine demonstrated 
statistically significant reduction in serogroup B and C colonisation following challenge at 
107 cfu per bird. Seroconversion of the vaccinated hens, as well as maternal transfer of 
antibodies to the egg yolk, was shown. Challenge (104 cfu per bird) trials with day-old 
chicks demonstrated a significant difference in colonisation of progeny from vaccinated 
versus non-vaccinated parents. The horizontal analysis over a three year period (2003 to 
2005) showed that the number of colonised flocks decreased by 10 % following vaccination 
and, if the vaccine titre mean was greater than 1000 the likelihood of persistent colonisation 
was reduced by 17 times. 
4.2 Prophylaxis trial 
It is well documented that young (< 3 woa) chicks lack a mature gut flora and immune 
system and therefore are more susceptible to Salmonella colonisation (Nurmi and Ratala 
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1973; Martin et al., 2000;). The transfer of maternal antibodies from the yolk to the chick may 
prevent colonisation of chicks by Salmonella (Hassan et al., 1996). 
The data summarised in Table 9 shows that maternal antibodies for Salmonella 
Typhimurium are transferred from hen serum to the egg yolk and these antibodies can be 
chemically extracted (Staak et al., 2001). However, there is a large variation in these data (15 
% to 80 %) in terms of the number of eggs that were positive for S. Typhimurium antibodies. 
This may be due to the level of seroconversion and the subsequent production of circulating 
antibody within the donor hen. Hamal et al. (2006) showed a relationship between plasma 
antibody levels and transfer into the yolk. These authors also noticed a farm difference in 
the serum antibody levels to the same vaccine, though, the serum to egg transfer rate was 
similar in both farms.  
The data in Table 9 shows that hens from farm 3, with a high flock mean Typhimurium 
serum (ELISA titre of 2104), also had 80 % of their yolks positive. These yolks, when 
chemically extracted, had a high crude extract mean anti-Typhimurium antibody titre 
(ELISA titre of 6900). The extract titres were higher than the initial serum level and similar 
observations have been made in numerous studies (Rose et al., 1974; Kariyawasam et al., 
2004; Malik et al., 2006; Yegani and Korver, 2010). 
The farm (1) that had the lowest levels of Typhimurium IgY was further investigated by 
performing repeats (n = 8) of each individual yolk tested (Figure 8). These data (Figure 8) 
showed that there was a lot of variation within the egg yolk as signified by the large 95% 
confidence limits error bars. This may be due to either mechanical error, such as difficultly 
in accurately pipetting 100 µl of highly viscous egg yolk, or that the amount of S. 
Typhimurium IgY present was so low that it reduced the probability of detection. An 
alternative method would be to weigh approximately 100 µg of egg yolk instead of 
pipetting. 
The yields of crude IgY which was chemically extracted (Staak et al., 2001) from egg yolks 
was higher (26 to 32 mg/g) than expected (20 to 25 mg/g) from another study employing 
the same method (Rose and Orlans, 1981). This higher yield may be due to the extraction of 
some low molecular weight proteins. This observation could be further investigated through 
electrophoretic analysis of the extracts to determine the size of the impurities. 
In the previous Section (4.1) it was shown that maternal antibody to S. Typhimurium can 
confer some protection to chicks challenged with low levels (104) of S. Typhimurium. This 
led to the hypothesis that feeding day old chicks rations supplemented with anti-
Typhimurium IgY may provide passive immunity. This hypothesis was based upon the 
review by Schade et al. (2005), which described many examples of transfer of antibody 
against specific pathogens from hyperimmunized hens into the egg. In recent years, there 
have been many trials that tested the efficacy of such antibodies against Salmonella in vitro 
(Lee et al., 2002; Chalghoumi et al., 2009a) and in vivo (Gurtler et al., 2004; Rahimi et al., 2007; 
Chalghoumi et al., 2009b). 
In the present trial the effects of IgY supplemented feeds on the growth rate, as well as 
protection from colonisation upon challenge with 104 and 105 cfu of S. Typhimurium, were 
evaluated; the challenge dose was based upon populations likely to be encountered 
naturally. The initial part of the trial was to observe and measure whether the chicks would 
consume the treated feeds and the effects of these on weight gain.  
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One of the concerns was the salt content in the crude yolk extract may make the feed 
unpalatable or that other antibodies in the crude yolk extract may interact adversely within 
the gastrointestinal tract thus affecting feed conversion. The results for this aspect of the trial 
are summarised in Figure 9 and show that there was no significant (Student t-test P = 0.56) 
difference in weight gain between the treated and control chicks, as shown by Kassaify and 
Mine (2004) in field trials.  
Chicks consumed a standard dose of 1.42 g antibody extract/chick/day. This dosage was 
calculated from Anonymous (2007) and was based upon 3 % (Gurtler et al., 2004) of daily 
intake at 11 days (trial midpoint) of age. 
The titre of the Typhimurium IgY in the treated feeds was measured daily (Figure 10) and 
showed that there was a high degree of variation in dosage. The feed treated with dried 
anti-Typhimurium egg yolk (dT-IgY), resuspended in crude S. Typhimurium containing IgY 
extract, and had the most consistent titre. The dried feed supplemented with 3 % dried egg 
yolk was the most variable. This may be due to the difficulty of evenly distributing the dried 
egg yolk throughout the ration; the titres in reconstituted (wet) feeds were much more 
consistent. 
Finally, after 15 days of age, the chicks were euthanized and their caeca removed for 
enumeration of S. Typhimurium (Figure 11). The results showed, regardless of the treatment 
and challenge level, that there was no significant difference (Student t-test P = 0.65) between 
treatment and control groups.  
The work performed by Kassaify and Mine (2004) measured the effects of egg yolk powder 
at 2.5 %, 5 %, 7.5 % and 10 % w : w and showed that Salmonella Typhimurium colonisation in 
poultry was eliminated at only the 10 % w : w concentration. The authors suggested that egg 
yolk containing anti-infection and adhesive factors, which may agglutinate the pathogen, 
stimulates the immune system or factors compete for adhesion sites (Kassaify and Mine, 
2004). 
Based on this result the concentration of egg yolk in the current trial, at 3 %, may have been 
too low and an insufficient amount of egg yolk containing anti-Typhimurium IgY reached 
the caeca. The former is supported by the work of Chalghoumi et al. (2009b) who also 
showed no significant caecal reduction in four-day-old chicks challenged with 106 cfu 
Typhimurium or Enteritidis fed 1 to 5 % (w:w) freeze dried egg yolk containing anti-
Salmonella IgY.  
The 3 % dose rate was based on the work of Gurtler et al. (2004), which demonstrated a 
significant reduction in S. Enteritidis contamination of eggs from hens that were challenged 
with high levels of Enteritidis (108 and 109). This challenge rate was not used in the present 
study as it was not considered to represent a natural infective dose. 
An alternate delivery method, IgY administered for 28 days in drinking water, led to a 
reduction in caecal colonisation of Enteritidis, administered at 106 cfu, to 0.27 log10 
compared to controls, at 3.98 log10/g (Rahimi et al., (2007). This method may be preferable to 
adding IgY directly into feed, as the water lines can be set to dose at a specific concentration. 
In standard Australian veterinary practice antimicrobials are added into water to treat 
disease and in feed for prophylactic treatment. 
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The initial concentration of egg yolk containing IgY may be critical as these orally-
administered antibodies, like any other protein molecule, are susceptible to denaturation by 
the acidic pH of the proventriculus and gizzard and degradation by proteases (Yegani and 
Korver, 2010). However, there are reports in the literature that suggest that the IgY Fab 
fragments maintain their ability to bind antigen, even after exposure to pepsin and trypsin 
and at pH 4.0 (Shimizu et al., 1988; Carlander et al., 2000; Gurtler et al., 2004). Therefore, there 
may be a percentage of the yolk containing IgY digested with only a limited portion still 
being active post-digestion. 
These antibodies, post-digestion, would decline in immunological activity and concentration 
as they progressed from the proximal to distal regions of the intestine, due to viscosity and 
passage rate, but remain detectable in the caecum and therefore reducing the probability of 
antibody encountering and binding the antigen (Reilly et al., 1997; Wilkie et al., 2006; Yegani 
and Korver, 2010). These factors may influence the ability of IgY to prevent colonisation by 
specific pathogens in the lower parts of the intestinal tract. It may be possible to develop a 
protease-resistant oral dosage form of IgY in order to increase the fraction of immuno-
reactive antibody delivered locally in the gastrointestinal tract (Reilly et al., 1997).  
The easiest method to ensure that effective concentration of IgY reaches the caeca is to 
ensure that the initial concentration of dried egg yolk is high enough to deliver a dosage of 
antibody inhibitory toward Salmonella into the caeca. The literature reviewed currently 
suggested that 10 % (w : w) would be the optimum dosage. 
In conclusion, this study demonstrated the successful chemical extraction of Typhimurium IgY 
transferred from serum to egg yolk for three different flocks. However, when yolk containing 
Typhimurium IgY was added to dry chick feed at 3 % (w:w) and fed prophylactically to day-
old chicks there was no protection observed when these chicks were challenged with S. 
Typhimurium (105 cfu/mL). This was possibly due to the feed dosage being too low or an 
inability of the orally administered antibodies to reach the site of activity required. 
5. Conclusion 
The autologus Salmonella tri-vaccine was shown to convey protection from colonisation of 
autologous and heterologous Salmonella challenge in the hen and to convey maternal 
antibodies to progeny. These maternal antibodies helped protect day-old chicks from 
colonisation after low-level challenge with Salmonella Typhimurium (at an age of 14 days). 
However, when these maternal antibodies were extracted from vaccinated hens’ eggs and 
fed to non-vaccinated day old chicks for prophylaxis there was no difference in caecal 
colonisation rates between treated and untreated groups. 
Reduction of the prevalence of Salmonella in flocks will benefit society by a potential 
reduction in human foodborne illness, as highlighted by a FAO/WHO (2002) risk 
assessment, which showed that for every 50 % reduction in prevalence there is also a 50 % 
reduction in risk. 
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